US Patent Issued to Sanofi on July 28 for "Tetrahydroisoquinoline derivatives for the treatment of red blood disorders and inflammatory diseases" (Moroccan Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,274, issued on July 28, was assigned to Sanofi (Paris).

"Tetrahydroisoquinoline derivatives for the treatment of red blood disorders and inflammatory diseases" was invented by Claude Barberis (Waltham, Morocco), George Karageorge (Waltham, Morocco), John Jurcak (Waltham, Morocco) and Kristen Terranova (Waltham, Morocco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds and compositions thereof for activating nuclear factor erythroid 2-related factor 2 (Nrf2) for treating red blood cell diseases and inflammatory diseases."

The patent was filed on Sept. 14, 2021, under Application No. 18/026,069.

*For further information, i...